HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models

by Al-Salemee, F., Barber, P.R, Beatson, R., Chowdhury, S., Galazi, M., Gómez, V., Leung, H.Y, Monypenny, J., Mullen, G., Ng, K., Ng, T., Orfi, L., Szokol, B., Vanhaesebroeck, B., Weitsman, G.
Published 2022

Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci

by Alnajar, H., Axcrona, K., Axcrona, U., Barbieri, C.E, Beg, S., Bhinder, B., Blattner-Johnson, M., Bogaard, M., Cai, P.Y, Calagua, C., Chinnaiyan, A.M, Croyle, J.A, Elemento, O., Fontugne, J., Johannessen, B., MacDonald, T.Y, Mosquera, J.M, Noorzad, Z., Park, K., Rubin, M.A, Sailer, V., Sanda, M.G, Scherr, D.S, Siddiqui, J., Skotheim, R.I, Ye, H.
Published 2022

Upregulated microRNA-126 induces apoptosis of dental pulp stem cell via mediating PTEN-regulated Akt activation

by Feng, X., Ge, R., Li, P., Lv, Y., Qi, H., Xu, L.
Published 2021

Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy

by Li, X., Liu, Y., Luo, L., Qin, X., Wu, L., Zhang, X.
Published 2021